 Merck  Co and GlaxoSmithKline PLC are holding off on providing help with outofpocket drug costs to people insured under the Affordable Care Act while other pharmaceutical companies go ahead amid mixed signals about whether the copay assistance is legal The help is a staple of pharmaceuticalindustry marketing to people insured by commercial health plans It costs drug makers billions of dollars a year But by subsidizing the outofpocket costs triggered by a prescription companies can help to ensure that the prescription
  